litlas
ログインアカウント作成

Scott Williams

1993–2025 年に発表

127
論文数
20,195
被引用数
78
h 指数
122
i10 指数

被引用数

Scott Williams の年別被引用数1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 5 件1994 年: 被引用 12 件1995 年: 被引用 24 件1996 年: 被引用 17 件1997 年: 被引用 22 件1998 年: 被引用 22 件1999 年: 被引用 28 件2000 年: 被引用 34 件2001 年: 被引用 57 件2002 年: 被引用 80 件2003 年: 被引用 48 件2004 年: 被引用 58 件2005 年: 被引用 64 件2006 年: 被引用 71 件2007 年: 被引用 68 件2008 年: 被引用 57 件2009 年: 被引用 49 件2010 年: 被引用 53 件2011 年: 被引用 85 件2012 年: 被引用 102 件2013 年: 被引用 86 件2014 年: 被引用 82 件2015 年: 被引用 68 件2016 年: 被引用 75 件2017 年: 被引用 91 件2018 年: 被引用 113 件2019 年: 被引用 451 件2020 年: 被引用 733 件2021 年: 被引用 1,061 件2022 年: 被引用 788 件2023 年: 被引用 688 件2024 年: 被引用 1,095 件2025 年: 被引用 505 件2026 年: 被引用 13 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,194 件、この内訳の 24.2%ドイツ: 引用元論文 742 件、この内訳の 8.2%イギリス: 引用元論文 624 件、この内訳の 6.9%中国: 引用元論文 615 件、この内訳の 6.8%オーストラリア: 引用元論文 490 件、この内訳の 5.4%イタリア: 引用元論文 482 件、この内訳の 5.3%カナダ: 引用元論文 437 件、この内訳の 4.8%フランス: 引用元論文 348 件、この内訳の 3.8%オランダ: 引用元論文 286 件、この内訳の 3.2%スイス: 引用元論文 283 件、この内訳の 3.1%日本: 引用元論文 231 件、この内訳の 2.6%スペイン: 引用元論文 217 件、この内訳の 2.4%
0%24.2%その他 23.3%

機関

分野

  • Medicine63.8%
  • Biochemistry, Genetics and Molecular Biology23.8%
  • Neuroscience4.1%
  • Immunology and Microbiology2.4%
  • Physics and Astronomy1.1%
  • Engineering0.7%
  • その他4.1%

トピック

  • Prostate Cancer Treatment and Research14.6%
  • Prostate Cancer Diagnosis and Treatment10.4%
  • Radiopharmaceutical Chemistry and Applications7.6%
  • Cancer, Lipids, and Metabolism1.9%
  • Advanced Radiotherapy Techniques1.9%
  • Medical Imaging Techniques and Applications1.8%
  • その他61.8%

共著者

全論文

検索で開く
  1. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

    著者: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad Martin, Mark Frydenberg, Ramdave Shakher, Lih‐Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marušić, A Matera, Alan Herschtal, Amir Iravani, Rodney J. Hicks, Scott Williams, Declan G. Murphy - The Lancet 2020 被引用: 1,962

  2. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Y. Zhang, Margaret McJannett, Martin R. Stockler, John Violet, Scott Williams, Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 被引用: 1,082

  3. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

    著者: Ian D. Davis, Andrew Martin, Martin R. Stockler, Stephen Begbie, Kim N., Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy Hague, Lisa G. Horvath, Anthony M. Joshua, Nicola Jane Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott North, Francis Parnis, Wendy R. Parulekar, David Pook, M. Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Emily Tu, Francisco Vera-Badillo, Scott Williams, Sonia Yip, Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney - New England Journal of Medicine 2019 被引用: 1,593

  4. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

    著者: Michael S. Hofman, John Violet, Rodney J. Hicks, Justin Ferdinandus, Sue Ping Thang, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Declan G. Murphy, Peter Eu, Price Jackson, Mark Scalzo, Scott Williams, Shahneen Sandhu - The Lancet Oncology 2018 被引用: 1,143

  5. Prostate cancer

    著者: Shahneen Sandhu, Caroline M. Moore, Edmund Chiong, Himisha Beltran, Robert G. Bristow, Scott Williams - The Lancet 2021 被引用: 561

  6. Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

    著者: John Violet, Price Jackson, Justin Ferdinandus, Shahneen Sandhu, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Sue Ping Thang, Peter Eu, Mark Scalzo, Declan G. Murphy, Scott Williams, Rodney J. Hicks, Michael S. Hofman - Journal of Nuclear Medicine 2018 被引用: 486

  7. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    著者: James P Buteau, Andrew Martin, Louise Emmett, Amir Iravani, Shahneen Sandhu, Anthony M. Joshua, Roslyn J. Francis, Alison Y. Zhang, Andrew M. Scott, Sze-Ting Lee, Arun Azad, Margaret McJannett, Martin R. Stockler, Scott Williams, Ian D. Davis, Michael S. Hofman, Tim Akhurst, Ramin Alipour, Arun Azad, Patricia Banks, Alexis Beaulieu, James P Buteau, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 被引用: 266

  8. Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James P Buteau, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R. Stockler, Scott Williams, Andrew Martin, Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 被引用: 199

  9. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

    著者: Christopher J. Sweeney, Andrew Martin, Martin R. Stockler, Stephen Begbie, Leanna Cheung, Kim N., Simon Chowdhury, Mark Frydenberg, Lisa G. Horvath, Anthony M. Joshua, Nicola Jane Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott North, Francis Parnis, Wendy R. Parulekar, David Pook, M. Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott Williams, Diana Winter, Sonia Yip, Alison Y. Zhang, Robert Zielinski, Ian D. Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Stephen Begbie, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle R. Cronk, Katharine Cuff, Ian D. Davis, Anthony Dowling, Mark Frydenberg, M. C. George, Lisa G. Horvath, Elizabeth Hovey, Anthony M. Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence E. Krieger, Gavin Marx, Maitham Mathlum, Louise Nott, Zulfiquer Otty, Francis Parnis, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Gwendolyn Stevanovic, Martin R. Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, H. E. A. Campbell, Kim Chi, Joseph L. Chin, E. Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastién J. Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Éric Vigneault, Paweł Zalewski, John McCaffrey, Ray McDermott, Patrick G. Morris, Miriam O’Connor, Paul Donnellan, Dearbhaile M. O’Donnell, Dearbhaile O'Donnell, Peter C.C. Fong, Alvin Tan, Simon Chowdhury ほか 13 名 - The Lancet Oncology 2023 被引用: 188

  10. Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

    著者: John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David A. Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G. Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott Williams, Rodney J. Hicks, Michael S. Hofman - Journal of Nuclear Medicine 2019 被引用: 286

  11. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    著者: Wanling Xie, Meredith M. Regan, Marc Buyse, Susan Halabi, Philip W. Kantoff, Oliver Sartor, Howard R. Soule, Noel W. Clarke, Laurence Collette, James J. Dignam, Karim Fizazi, Wendy R. Paruleker, Howard M. Sandler, Matthew R. Sydes, Bertrand Tombal, Scott Williams, Christopher J. Sweeney, on behalf of the ICECaP Working Group - Journal of Clinical Oncology 2017 被引用: 434

  12. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study

    著者: Geoffrey D. Coughlin, John Yaxley, Suzanne K. Chambers, Stefano Occhipinti, Hemamali Samaratunga, Leah Zajdlewicz, Patrick Telöken, Nigel Dunglison, Scott Williams, Martin F. Lavin, Robert A. Gardiner - The Lancet Oncology 2018 被引用: 461

  13. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

    著者: Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne, Richard Fisher, Mark Frydenberg, Alan Herschtal, Scott Williams, Chris Brown, Warick Delprado, Annette Haworth, David Joseph, Jarad Martin, J. H. Matthews, Jeremy Millar, Mark Sidhom, Nigel Spry, Colin Tang, Sandra Turner, Kirsty Wiltshire, Henry H. Woo, Ian D. Davis, Tee Lim, Maria Pearse - The Lancet Oncology 2020 被引用: 363

  14. LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC).

    著者: Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Mathias Bressel, Rhonda Huynh, Patricia Banks, Roslyn Wallace, Anis Hamid, Andrisha Jade Inderjeeth, Ben Tran, Arun Azad, Ramin Alipour, Grace Kong, Aravind Ravi Kumar, Javad Saghebi, Scott Williams, Timothy Akhurst, Rodney J. Hicks, Michael S. Hofman - Journal of Clinical Oncology 2023 被引用: 78

  15. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

    著者: John Yaxley, Geoffrey D. Coughlin, Suzanne K. Chambers, Stefano Occhipinti, Hemamali Samaratunga, Leah Zajdlewicz, Nigel Dunglison, Rob Carter, Scott Williams, Diane Payton, Joanna Perry‐Keene, Martin F. Lavin, Robert A. Gardiner - The Lancet 2016 被引用: 696

  16. Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617

    著者: Justin Ferdinandus, John Violet, Shahneen Sandhu, Rodney J. Hicks, Aravind S. Ravi Kumar, Amir Iravani, Grace Kong, Tim Akhurst, Sue Ping Thang, Declan G. Murphy, Scott Williams, Michael S. Hofman - European Journal of Nuclear Medicine and Molecular Imaging 2020 被引用: 155

  17. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study

    著者: Renu Eapen, James P Buteau, Price Jackson, Catherine Mitchell, Sheng F. Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark Scalzo, J O’Brien, Shahneen Sandhu, Arun Azad, Scott Williams, Gaurav Sharma, Mohammad B. Haskali, Mathias Bressel, Kenneth Chen, Pocharapong Jenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J. Neeson, Declan G. Murphy, Michael S. Hofman - European Urology 2023 被引用: 84

  18. Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy

    著者: Sue Ping Thang, John Violet, Shahneen Sandhu, Amir Iravani, Tim Akhurst, Grace Kong, Aravind Ravi Kumar, Declan G. Murphy, Scott Williams, Rodney J. Hicks, Michael S. Hofman - European Urology Oncology 2018 被引用: 183

  19. TheraP: a randomized phase 2 trial of 177 Lu‐ PSMA ‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

    著者: Michael S. Hofman, Louise Emmett, John Violet, Alison Y. Zhang, Nicola Jane Lawrence, Martin R. Stockler, Roslyn J. Francis, Amir Iravani, Scott Williams, Arun Azad, Andrew Martin, Margaret McJannett, ANZUP TheraP team, Ian D. Davis - British Journal of Urology 2019 被引用: 162

  20. PRINCE: Phase I trial of 177Lu-PSMA-617 in combination with pembrolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC).

    著者: Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, A. Antón, Roslyn Wallace, Anupama Pasam, Mathias Bressel, Eoin Cassidy, Patricia Banks, Nattakorn Dhiantravan, Timothy Akhurst, Aravind Ravi Kumar, Ramin Alipour, Mark Scalzo, Scott Williams, Rodney J. Hicks, Michael S. Hofman - Journal of Clinical Oncology 2022 被引用: 60

  21. A Role for the Primary Cilium in Notch Signaling and Epidermal Differentiation during Skin Development

    著者: Ellen J. Ezratty, Nicole Stokes, Sophia Chai, Alok S. Shah, Scott Williams, Elaine Fuchs - Cell 2011 被引用: 322

  22. UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol)

    著者: Nattakorn Dhiantravan, Louise Emmett, Anthony M. Joshua, David A. Pattison, Roslyn J. Francis, Scott Williams, Shahneen Sandhu, Ian D. Davis, Ian Vela, Nitika Neha, Mathias Bressel, Declan G. Murphy, Michael S. Hofman, Arun Azad - British Journal of Urology 2021 被引用: 63

  23. P53: A Guardian of Immunity Becomes Its Saboteur through Mutation

    著者: Arjelle Decasa Agupitan, Paul J. Neeson, Scott Williams, Jason Howitt, Sue Haupt, Ygal Haupt - International Journal of Molecular Sciences 2020 被引用: 99

  24. Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

    著者: Rafael Emilio de Feria Cardet, Michael S. Hofman, Tatiana Segard, Jackie Yim, Scott Williams, Roslyn J. Francis, Mark Frydenberg, Nathan Lawrentschuk, Declan G. Murphy, Richard De Abreu Lourenço - European Urology 2020 被引用: 97